Hostname: page-component-77f85d65b8-hzqq2 Total loading time: 0 Render date: 2026-03-27T15:05:08.583Z Has data issue: false hasContentIssue false

Emotion Recognition and Traffic-Related Risk-Taking Behavior in Patients with Neurodegenerative Diseases

Published online by Cambridge University Press:  19 August 2020

Nils S. van den Berg*
Affiliation:
University of Amsterdam, Department of Brain and Cognition, Nieuwe Achtergracht 129B, P.O. Box 15.915, 1001 NK Amsterdam, The Netherlands University of Groningen, University Medical Center Groningen, Department of Neurology, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
Fransje E. Reesink
Affiliation:
University of Groningen, University Medical Center Groningen, Department of Neurology, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
Edward H.F. de Haan
Affiliation:
University of Amsterdam, Department of Brain and Cognition, Nieuwe Achtergracht 129B, P.O. Box 15.915, 1001 NK Amsterdam, The Netherlands
Hubertus P.H. Kremer
Affiliation:
University of Groningen, University Medical Center Groningen, Department of Neurology, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
Jacoba M. Spikman
Affiliation:
University of Groningen, University Medical Center Groningen, Department of Neurology, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
Rients B. Huitema
Affiliation:
University of Groningen, University Medical Center Groningen, Department of Neurology, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands
*
*Correspondence and reprint requests to: Nils Sven van den Berg, University Medical Center Groningen, Department of Neurology, Unit Neuropsychology HPC AB60, Hanzeplein 1, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. Tel: +316 42137777. E-mail: n.s.vandenberg@uva.nl
Rights & Permissions [Opens in a new window]

Abstract

Objectives:

Neurodegenerative diseases (NDDs), such as Alzheimer’s disease, frontotemporal dementia, dementia with Lewy bodies, and Huntington’s disease, inevitably lead to impairments in higher-order cognitive functions, including the perception of emotional cues and decision-making behavior. Such impairments are likely to cause risky daily life behavior, for instance, in traffic. Impaired recognition of emotional expressions, such as fear, is considered a marker of impaired experience of emotions. Lower fear experience can, in turn, be related to risk-taking behavior. The aim of our study was to investigate whether impaired emotion recognition in patients with NDD is indeed related to unsafe decision-making in risky everyday life situations, which has not been investigated yet.

Methods:

Fifty-one patients with an NDD were included. Emotion recognition was measured with the Facial Expressions of Emotions: Stimuli and Test (FEEST). Risk-taking behavior was measured with driving simulator scenarios and the Action Selection Test (AST). Data from matched healthy controls were used: FEEST (n = 182), AST (n = 36), and driving simulator (n = 18).

Results:

Compared to healthy controls, patients showed significantly worse emotion recognition, particularly of anger, disgust, fear, and sadness. Furthermore, patients took significantly more risks in the driving simulator rides and the AST. Only poor recognition of fear was related to a higher amount of risky decisions in situations involving a direct danger.

Conclusions:

To determine whether patients with an NDD are still fit to drive, it is crucial to assess their ability to make safe decisions. Measuring emotion recognition may be a valuable contribution to this judgment.

Information

Type
Regular Research
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © INS. Published by Cambridge University Press, 2020
Figure 0

Table 1. Descriptive statistics of the three HC groups, the total patient group, and the subgroups of patients

Figure 1

Table 2. Performance on the FEEST and the AST for all subgroups of patients as well as comparisons between all patient subgroups (Kruskall–Wallis H-tests)

Figure 2

Table 3. Performance on the FEEST, the AST, and the driving simulator (means and SDs) and comparisons between HCs and patients (MWU-tests or ANCOVA for the AST, with age and educational level added as covariates)

Figure 3

Table 4. Partial correlations in the patient group between the FEEST scores and the AST, Swing-SDLP and inters-viol, with age as covariate